Preliminary experiments point out conolidine may inhibit unique ion channels, reducing neuronal excitability and restricting agony indicators. This system is particularly suitable in neuropathic suffering, wherever irregular signaling triggers persistent irritation. Moreover, conolidine appears to influence G protein-coupled receptor (GPCR) pathway